Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 5/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 4/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2425000 | 1.00 | TBXAS1 (0.33) | TBXAS1USP2NPSR1CNR1CNR2 | |
| SCHEMBL2426403 | 0.82 | USP2 (0.35) | USP2NPSR1 | |
| SCHEMBL2431308 | 0.81 | USP2 (0.35) | USP2NPSR1 | |
| SCHEMBL2427834 | 0.81 | USP2 (0.35) | USP2NPSR1 | |
| SCHEMBL2424981 | 0.81 | USP2 (0.35) | USP2NPSR1 | |
| SCHEMBL2427837 | 0.81 | USP2 (0.35) | USP2NPSR1 | |
| SCHEMBL2428480 | 0.81 | USP2 (0.35) | USP2NPSR1 | |
| SCHEMBL2427596 | 0.81 | USP2 (0.35) | USP2NPSR1 | |
| SCHEMBL2424984 | 0.81 | USP2 (0.35) | USP2NPSR1 | |
| SCHEMBL2428359 | 0.81 | USP2 (0.35) | USP2NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2094650-B1 | USE OF CAMPHOLENIC DERIVATIVES AS FRAGRANT INGREDIENTS IN PERFUMERY AND FLAVOURING | MANE FILS V (FR) | 2011-09-21 | — | — | EP | claimed |
| EP-2094650-A1 | USE OF CAMPHOLENIC DERIVATIVES AS FRAGRANT INGREDIENTS IN PERFUMERY AND FLAVOURING | V. Mane Fils (FR) | 2009-09-02 | — | — | EP | claimed |
| US-20080138482-A1 | USE OF NEW CAMPHOLENIC DERIVATIVES AS FRAGRANT INGREDIENTS IN PERFUMERY AND FLAVOURING | V. MANE FILS (FR) | 2008-06-12 | — | — | US | claimed |
| WO-2008068310-A1 | USE OF CAMPHOLENIC DERIVATIVES AS FRAGRANT INGREDIENTS IN PERFUMERY AND FLAVOURING | V. MANE FILS (FR) | 2008-06-12 | — | — | WO | claimed |
| EP-1930317-A1 | Use of campholenic derivatives as fragrant ingredients in perfumery and flavouring | V. Mane Fils (FR) | 2008-06-11 | — | — | EP | claimed |
| EP-2094650-B1 | USE OF CAMPHOLENIC DERIVATIVES AS FRAGRANT INGREDIENTS IN PERFUMERY AND FLAVOURING | MANE FILS V (FR) | 2011-09-21 | — | — | EP | disclosed |
| EP-2094650-A1 | USE OF CAMPHOLENIC DERIVATIVES AS FRAGRANT INGREDIENTS IN PERFUMERY AND FLAVOURING | V. Mane Fils (FR) | 2009-09-02 | — | — | EP | disclosed |
| US-20080138482-A1 | USE OF NEW CAMPHOLENIC DERIVATIVES AS FRAGRANT INGREDIENTS IN PERFUMERY AND FLAVOURING | V. MANE FILS (FR) | 2008-06-12 | — | — | US | disclosed |
| WO-2008068310-A1 | USE OF CAMPHOLENIC DERIVATIVES AS FRAGRANT INGREDIENTS IN PERFUMERY AND FLAVOURING | V. MANE FILS (FR) | 2008-06-12 | — | — | WO | disclosed |
| EP-1930317-A1 | Use of campholenic derivatives as fragrant ingredients in perfumery and flavouring | V. Mane Fils (FR) | 2008-06-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080138482-A1 | USE OF NEW CAMPHOLENIC DERIVATIVES AS FRAGRANT INGREDIENTS IN PERFUMERY AND FLAVOURING | C5, C3AR1, PDE6D | TBXAS1 818/4885USP2 3867/4885NPSR1 2895/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.